Amarin Corporation CEO, John Thero, to Chair the American Heart Association’s Heart & Stroke Ball in New York City NEW YORK, BEDMINSTER, N.J., and DUBLIN, Ireland, March 21, 2017 (GLOBE NEWSWIRE) -- The American Heart Association and American Stroke Association announced today that John Thero will serve as...

Amarin Reaches the Onset of Approximately 80% of the Target Aggregate Number of Primary Major Adverse Cardiovascular Events Within the REDUCE-IT Study BEDMINSTER, N.J., and DUBLIN, Ireland, March 16, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of...